InsidersTradesSigma
Follow the カルナバイオサイエンス株式会社 share price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, カルナバイオサイエンス株式会社 has recorded 26 insider filings. Market capitalisation: €6.3bn. The latest transaction was filed on 29 July 2026 (Holding update). Among the most active insiders: Cantor Fitzgerald & Co.. Every trade is accessible without an account.
26
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 July 2026
Declarations26 total
2.73% mcap6.1% of flowShareXTKSEDINET:S100YSVX
3.67% mcap10.1% of flowShareXTKSEDINET:S100Y83T
0.021% mcap26.5% of flowShareXTKSEDINET:S100Y1G1
0.022% mcap26.5% of flowShareXTKSEDINET:S100XZ8H
22.3% of flowShareXTKSEDINET:S100XMIT
100.0% of flowShareXTKSEDINET:S100XFAC
32.5% of flowShareXTKSEDINET:S100X7GI
22.7% of flowShareXTKSEDINET:S100WTBA
22.5% of flowShareXTKSEDINET:S100WT4U
ShareXTKSEDINET:S100UKAF
47.1% of flowShareXTKSEDINET:S100UK3G
ShareXTKSEDINET:S100UHOD
ShareXTKSEDINET:S100SKU3
ShareXTKSEDINET:S100SBSG
ShareXTKSEDINET:S100RKDX
5.6% of flowShareXTKSEDINET:S100QECM
6.6% of flowShareXTKSEDINET:S100QDQV
7.1% of flowShareXTKSEDINET:S100QB0V
7.5% of flowShareXTKSEDINET:S100Q9SF
8.6% of flowShareXTKSEDINET:S100Q207
9.5% of flowShareXTKSEDINET:S100Q0G4
9.5% of flowShareXTKSEDINET:S100Q0DJ
10.1% of flowShareXTKSEDINET:S100PZBQ
11.4% of flowShareXTKSEDINET:S100PWAB
11.7% of flowShareXTKSEDINET:S100PTEQ
25 of 26 declarations
About カルナバイオサイエンス株式会社
Karuna Biosciences is a company focused on the healthcare and pharmaceutical sector. It is listed on the XTKS market.